our Premium Content: News alerts, weekly reports and conference planners
DRUG:
AU-101
i
Other names: AU-101, AU101, AU 101, Autologous HER2-specific T cells, HER2-specific T cells, HER2 chimeric antigen receptor expressing T cell therapy, HER2-CART
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
P1, N=10, Active, not recruiting, Baylor College of Medicine | Recruiting --> Active, not recruiting | N=28 --> 10 | Trial completion date: Jan 2036 --> Apr 2037
over 1 year ago
Enrollment closed • Enrollment change • Trial completion date